Position in NTRA
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$19,001
+$14,802 QoQ
Shares Held
70
+233.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#727
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $1,362,345 across 21 Diagnostics & Research names. NTRA ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
857 | $429,665 | |
| 2 | WAT |
Waters Corp /De/
|
709 | $265,903 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,073 | $227,422 | |
| 4 | DHR |
Danaher Corp /De/
|
723 | $137,717 | |
| 5 | ILMN |
Illumina, Inc.
|
650 | $114,289 | |
| 6 | LH |
Labcorp Holdings Inc.
|
254 | $71,120 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
83 | $43,694 | |
| 8 | A |
Agilent Technologies, Inc.
|
149 | $19,791 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,001 | 70 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,199 | 21 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $4,581 | 20 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $3,219 | 20 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,378 | 20 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,828 | 20 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,691 | 17 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||